References
- Feinberg AP . The epigenetics of cancer etiology. Semin. Cancer Biol.14 , 427–432 (2004).
- Perry AS , WatsonRW, LawlerM et al. The epigenome as a therapeutic target in prostate cancer. Nat. Rev. Urol. 7 , 668–680 (2010).
- van Leenders GJ , DukersD, HesselsD et al. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features. Eur. Urol. 52 , 455–463 (2007).
- Babbio F , PistoreC, CurtiL et al. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression. Oncogene doi:10.1038/onc.2011.641 (2012) (Epub ahead of print).
- Dillon N . Heterochromatin structure and function. Biol. Cell96 , 631–637 (2004).
- Kim JK , EstevePO, JacobsenSE et al. UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucleic Acids Res. 37 , 493–505 (2008).
- Unoki M , BrunetJ, MousliM. Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis. Biochem. Pharmacol.78 , 1279–1288 (2009).
References
- Kuzmichev A , NishiokaK, Erdjument-BromageH, TempstP, ReinbergD. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev.16 , 2893–2905 (2002).
- Müller J , HartCM, FrancisNJ et al. Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell 111 , 197–208 (2002).
- Cao R , WangL, WangH et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298 , 1039–1043 (2002).
- Simon JA , LangeCA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat. Res.647 , 21–29 (2008).
- Morin RD , JohnsonNA, SeversonTM et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet. 42 , 181–185 (2010).
- Wigle TJ , KnutsonSK, JinL et al. The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states. FEBS Lett. 585 , 3011–3013 (2011).
- McCabe MT , GravesAP, GanjiG et al. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). Proc. Natl Acad. Sci. 109(8) , 2989–2994 (2012).
- Velichutina I , ShaknovichR, GengH et al. EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood 116 , 5247–5255 (2010).
References
- Lefebvre V , DumitriuB, Penzo-MendezA et al. Control of cell fate and differentiation by Sry-related high-mobility-group box (SOX) transcription factors. Int. J. Biochem. Cell Biol. 39 , 2195–2214 (2007).
- Blache P , van de Wetering M, Duluc I et al. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J. Cell Biol.166 , 37–47 (2004).
- Sun M , UozakiH, HinoR, KunitaA et al. SOX9 expression and its methylation status in gastric cancer. Virchows Arch.460(3) , 271–279 (2012).
- Uozaki H , FukayamaM. Epstein–Barr virus and gastric carcinoma – viral carcinogenesis through epigenetic mechanisms. Int. J. Clin. Exp. Pathol.1 , 198–216 (2008).
- Fukayama M , HinoR, UozakiH. Epstein–Barr virus and gastric carcinoma: virus–host interactions leading to carcinoma. Cancer Sci.99 , 1726–1733 (2008).
- Chen Y , Zhang Y-Z, Zhou Z-G et al. Identification of differently expressed genes in human colorectal adenocarcinoma. World J. Gastroenterol.12 , 1025–1032 (2006).
References
- Jemal A , SiegelR, WardE et al. Cancer statistics. Cancer J. Clin. 59 , 225–249 (2009).
- Zhang DD . Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev.38 , 769–789 (2006).
- Cho HY , ReddySP, DebiaseA et al. Gene expression profiling of the NRF2-mediated protection against oxidative injury. Free Radic. Biol. Med. 38 , 325–343 (2005).
- Kobayashi A , KangMI, WataiY et al. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell Biol. 26 , 221–229 (2006).
- Kaspar JW , NitureSK, JaiswalAK. Antioxidant-induced Inrf2 (Keap1) tyrosine 85 phosphorylation controls the nuclear export and degradation of the Inrf2-Cul3-Rbx1 complex to allow normal Nrf2 activation and repression. J. Cell Sci.125 , 1027–1038 (2012).
- Hanada N , TakahataT, ZhouQ et al. Methylation of the KEAP1 gene promoter region in human colorectal cancer. BMC Cancer 12 , 66 (2012).
- Wang R , AnJ, JiF et al. Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues. Biochem. Biophys. Res. Commun. 373 , 151–154 (2008).
- Zhang P , SinghA, YegnasubramanianS et al. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol. Cancer Ther. 9 , 336–346 (2010).